precursor T-lymphoblastic leukemia/lymphoma

From Aaushi
Jump to navigation Jump to search

Epidemiology

  • most common in young men

Genetics

Clinical manifestations

Laboratory

Management

More general terms

More specific terms

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
  2. Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 519
  3. 3.0 3.1 Bankhead C Anti-CD7 CAR-T Therapy Yields High Response Rate in Acute Leukemia. Complete responses in 18 of 20 patients with relapsed/refractory T-cell ALL. MedPage Today August 4, 2021 https://www.medpagetoday.com/hematologyoncology/leukemia/93902
    Pan J, Tan Y, Wang G et al Donor-derived CD7 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia: First-in-human, phase I trial. J Clin Oncol. 2021. Jul 29 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34324392 https://ascopubs.org/doi/abs/10.1200/JCO.21.00389

Database